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A
DP is generated in some of the most funda-
mental biological reactions, catalyzed by two
large classes of enzymes, ATPases and kinases.
ATP hydrolysis provides the energy for a large number
of cellular processes, mediated by ATPases. Kinases are
important both in metabolic pathways and in protein
phosphorylation, which play a central role in cellular sig-
nal transduction. Methods to assay the ADP product
are, therefore, of great importance to study these enzy-
maticreactions,bothtounderstandtheenzymes’mech-
anism of action and to develop inhibitors for therapeu-
tic intervention. Notably, protein kinases are the second
most important target for drug screening, following
G-protein coupled receptors. ATPases produce free
phosphate in addition to ADP, and therefore their activ-
ity can be monitored using phosphate detection assays,
for example, malachite green (1). Kinases transfer the
terminal phosphate from ATP onto a substrate, such as
a protein, lipid, or sugar, releasing only ADP as a com-
mon product of all kinases. Detection of the phosphory-
lated products requires an assay to be developed for
each individual kinase under study. In contrast, ADP-
speciﬁc sensors provide a generic method to measure
the activity of any ATPase or kinase. However, the num-
ber of optical assays for ADP detection is still very lim-
ited. Examples include coupled enzyme assays (2) and
recognition by speciﬁc RNA molecules (3) or by anti-
bodies (4–6).
Recently we reported a ﬂuorescent, reagentless bio-
sensor for ADP, based on a bacterial actin homologue,
ParM, which has a functional role in plasmid segrega-
tion in vivo (7). The rational design of that sensor relied
on the large conformational change in ParM that results
from ADP binding (8). In the nucleotide-free state ParM
is in an open conformation, but when ADP binds there is
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ABSTRACT Fluorescence assays for ADP detection are of considerable current
interest, both in basic research and in drug discovery, as they provide a generic
method for measuring the activity of ATPases and kinases. The development of a
novel ﬂuorescent biosensor is described that is based on a tetramethylrhodamine-
labeled,bacterialactinhomologue,ParM.Thedesignofthebiosensortakesadvan-
tage of the large conformational change of ParM on ADP binding and the strong
quenching of the tetramethylrhodamine ﬂuorescence by stacking of the dye. ParM
was labeled with two tetramethylrhodamines in close proximity, whereby the ﬂu-
orophores are able to interact with each other. ADP binding alters the distance and
relative orientation of the tetramethylrhodamines, which leads to a change in this
stacking interaction and so in the ﬂuorescence intensity. The ﬁnal ADP biosensor
shows 15-fold ﬂuorescence increase in response to ADP binding. It has relatively
weak afﬁnity for ADP (Kd30 M), enabling it to be used at substoichiometric con-
centrations relative to ADP, while reporting ADP concentration changes in a wide
range around the Kd value, namely, submicromolar to tens of micromolar. The bio-
sensor strongly discriminates against ATP (100-fold), allowing ADP detection
against a background of millimolar ATP. At 20 °C, the labeled ParM binds ADP with
a rate constant of 9.5  104 M1 s1 and the complex dissociates at 2.9 s1. Thus,
the biosensor is suitable for real-time measurements, and its performance in such
assays is demonstrated using a sugar kinase and a mammalian protein kinase.
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ing the nucleotide binding cleft. This conformation
change was coupled to an optical signal by the attach-
ment of a single coumarin ﬂuorophore, which is sensi-
tive to environmental changes (7). Any ADP sensor must
discriminate successfully against ATP, which would nor-
mally be present in the assay solution, possibly at high
concentration. By mutagenesis, ParM was further engi-
neered to achieve strong discrimination against triphos-
phate binding and to suppress ﬁlament formation that
occurs in the native protein.
The coumarin-based biosensor MDCC-ParM provides
a method for real-time detection of ADP at submicro-
molarconcentrations,suchasintransientkineticexperi-
ments. However, due to its low dissociation constant of
ADP (0.5 M), excess MDCC-ParM over ADP is needed
when measuring ADP concentrations of 0.5 M. In ad-
dition, the dissociation constant of ATP (200 M), al-
beit much greater than that of ADP, imposes an upper
limit on the ATP concentration that can be used.
For several types of assay, criteria such as high sensi-
tivity and fast signal response are not crucial. Such as-
says would include high-throughput screening and
many steady-state measurements. Instead, important
criteria may include optical stability, a wide concentra-
tion range, in this case of ADP being measured with ATP
present, and low reagent usage. Coumarins, as used in
the biosensor that was outlined above (7), have limited
photostability (9), and this may be problematic in appli-
cations where high-intensity light sources or long illumi-
nation periods are used. In addition, assay compo-
nents may potentially interfere with the optical signal,
because the excitation/emission wavelengths of cou-
marins are relatively low (10–12). As mentioned above,
relatively high amounts of labeled protein are required,
and this may be experimentally inaccessible, for ex-
ample, due to inner ﬁlter effects. Both the target ADP
range and reagent usage can be addressed by having
a biosensor that reports the ADP concentration without
stoichiometric binding and so the concentration of the
biosensor can be kept low relative to the ADP being
measured. In effect, this issue can be resolved if the bio-
sensor binds ADP weakly.
The development of an ADP biosensor is described
here to achieve these aims. The new biosensor is also
based on ParM but using a different strategy for signal
generation, which relies on formation and dissociation
of tetramethylrhodamine stacking. This approach takes
advantage of the large difference in rhodamine ﬂuores-
cence depending on whether the ﬂuorophore is in a
monomeric or stacked state. The basis for the ﬂuores-
cencequenchinginthestackedstateisexcitoncoupling
(13–15). This strategy has been used to monitor cleav-
age of small peptides by proteases, such as elastase
and the malaria protease, PfSUB-1 (16–18). When at-
tached to both ends of a peptide, tetramethylrhoda-
mines form the stacking interaction, which largely
quenches their ﬂuorescence. This interaction is lost
upon cleavage of the peptide yielding an up to 30-fold
increase in ﬂuorescence intensity (14). The same ap-
proach has been used to monitor dissociation of protein
complexes and conformation changes in proteins (19,
20), where the distance or relative orientation of two at-
tached tetramethylrhodamines alters. An example is a
phosphate biosensor that is based on a doubly
rhodamine-labeled phosphate binding protein, yielding
a 20-fold ﬂuorescence increase upon ligand binding
(19).
By applying the two-rhodamine strategy to ParM, a
new ADP biosensor was developed with characteristics
very different from those of MDCC-ParM, previously re-
ported(7).TheParMvariant,labeledwithtwotetrameth-
ylrhodamines, binds ADP with relatively weak afﬁnity
(dissociation constant 30 M) but responds to ADP
binding with 15-fold signal increase. This means that
thetetramethylrhodamine-basedbiosensorcanbeused
at substoichiometric concentrations, relative to ADP.
The sensor strongly discriminates against ATP (Kd
3 mM) and thus enables detection of a wide range of
ADP against a background of high ATP concentrations.
RESULTS AND DISCUSSION
Attachment Sites for Double Rhodamine Labeling. In
order to label ParM with two tetramethylrhodamines in
positions where stacking might occur between them,
two accessible cysteine residues were required as spe-
ciﬁc attachment sites on either side of the nucleotide
binding cleft (8) (Supplementary Figure 1). The natural
exposed cysteine in the wild-type protein was not in a
suitable position to provide such a labeling site and was
mutated to alanine. Two cysteine mutations were intro-
duced into this ParM mutant (C287A). Two pairs were
chosen, D63C/D224C and D63C/K216C, on the basis
of the structure (8), consideration of distances between
labeling sites relative to the structure of the stacked tet-
ramethylrhodamines (18), and previous work with tetra-
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(19). Amino acid positions 224 and 216 are located on
helix 8 in subdomain IIB. Position 63 is situated in a
loop on the opposing subdomain, which moves away
from helix 8 upon ADP binding (Supplementary
Figure 1). In the nucleotide-free conformation a tetra-
methylrhodamine pair attached to these positions
should be able to stack, and this interaction may be dis-
rupted when ADP binding induces domain movement.
Test labeling of the two double mutants was done
with two rhodamine isomers, 5-IATR and 6-IATR (5- and
6-iodoacetamidotetramethylrhodamine), and the ﬂuo-
rescence response to ADP binding was measured. The
labeling stoichiometry was 2:1 as conﬁrmed by mass
spectrometry. All four combinations showed an increase
in ﬂuorescence on addition of ADP, as expected for the
disruption of rhodamine dimers. The larger signal
change was observed for ParM (D63C/D224C/C287A)
with a 10-fold ﬂuorescence increase when labeled with
6-IATR (Table 1). In contrast, the ﬂuorescence change
obtained with ParM (D63C/K216C/C287A) was 3-fold
with both tetramethylrhodamine isomers and this could
not be improved by further puriﬁcation of the labeled
proteins. Therefore ParM (D63C/D224C/C287A) was
chosen for further work.
Optimization of the Biosensor by Mutagenesis. The
dissociation constants of ADP binding to 5-IATR- and
6-IATR-labeled ParM (D63C/D224C/C287A) were deter-
mined by ﬂuorescence titration to be 76 3 and 147 
8 M, respectively (Figure 1, Table 1). These afﬁnities
are orders of magnitude lower than those of wild-type
ParM (2.4 M) (21) or the MDCC-labeled ParM version
(0.46 M) (7). ATP binds considerably weaker than ADP
in both cases, Kd 1 mM, and the ﬂuorescence change
upontriphosphatebindingwaslower(Figure1,Table1).
In order to improve ADP selectivity further two active site
mutations, T174A and T175N, were introduced into the
ParM variant for tetramethylrhodamine labeling. The
TABLE 1. Fluorescence changes, nucleotide afﬁnities, and binding dynamics of different
tetramethylrhodamine-labeled ParM mutants
Fluorescence titrationa Kineticsb
ADP ATP ADP
Mutations
in addition
to D63C, D224C,
C287A (F/F) Kd(M) (F/F) Kd(M)
Kdratio
ATP/ADP kon (M1s1) koff (s1)( Kd)b(M)
5-IATR
No additional
mutation
4.1 0.5 76 3 1.9 0.1 1200 200 16 3 n.d. n.d. n.d.
T174A T175N 18.7 0.9 63 3 6.0 5000 80 0.065 0.001 4.2 0.2 65 4
K33A T174A
T175N
14.9 0.6 30.2 0.9 5.0 3000 100 0.095 0.007 2.9 0.1 30 4
6-IATR
No additional
mutation
10 1 147 8 3.7 0.5 1100 100 8 1 n.d. n.d. n.d.
T174A T175N 18.9 0.6 103 2 7.0 5000 50 0.055 0.002 6.2 0.2 110 10
K33A T174A
T175N
14.5 0.6 37 3 4.0 3000 80 0.074 0.003 3.3 0.3 45 6
aFluorescence titrations were performed as in Figure 1 to determine the equilibrium dissociation constants (Kd) and ﬂuorescence changes (F	/F−)
upon ADP and ATP binding. Except for the ﬁnal variant, 5-ATR-ParM (K33A/D63C/T174A/T175N/D224C/C287A), the ﬂuorescence change varied be-
tween different batches of labeled protein, since the labeling conditions for the other mutants have not been optimized. Values given in the table rep-
resent the maximum ﬂuorescence change observed . bStopped-ﬂow experiments were carried out at 20 °C as described in Figure 3 to determine
the association (kon) and dissociation (koff) rate constants for ADP binding. Dissociation constants (Kd) were calculated from koff/kon.
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ATP afﬁnity in the MDCC-ParM biosensor (7). The new
ParM mutant (His6/D63C/T174A/T175N/D224C/
C287A), labeled with either 5-IATR or 6-IATR, had slightly
increased ADP afﬁnity, but the mutations weakened
ATP binding to 5 mM, thus greatly improving ADP se-
lectivity (Table 1).
Polymerization of 5-IATR- and 6-IATR-labeled ParM
(His6/D63C/T174A/T175N/D224C/C287A) was investi-
gated by right-angle light scattering (data not shown).
Both formed ﬁlaments in the presence of high ATP con-
centrations (4 mM), albeit much slower than the wild-
type protein (21, 22). Therefore an additional mutation
(K33A), known to inhibit ﬁlament formation (7, 23), was
introduced into ParM (His6/D63C/T174A/T175N/
D224C/C287A). The new ParM variant, labeled with 5-
or 6-IATR, did not show any change in light scattering,
even at high ParM concentrations (20 M) and long in-
cubation times (4 h) (data not shown). Thus the K33A
mutation effectively blocks ﬁlament formation. The ﬁnal
versions of the ParM (His6/K33A/D63C/T174A/T175N/
D224C/C287A) are hereafter called 5-ATR-(acetamido-
tetramethylrhodamine)-ParM and 6-ATR-ParM.
Absorbance and Fluorescence Spectra of 5- and
6-ATR-ParM. Fluorescence spectra and absorbance
spectra of 5-ATR- and 6-ATR-ParM were measured in
the absence and presence of ADP (Figure 2). The absor-
bance spectrum of 6-ATR-ParM in the absence of ADP
is indicative of tetramethylrhodamine stacking with
maximum absorbance at 519 nm and a shoulder
around 550 nm (Figure 2, panel a). ADP binding causes
an absorbance decrease at 519 nm and a concomitant
increase in absorbance at 553 nm, indicating that the
stacking is disturbed by ADP binding. The absorbance
spectrashowanisosbesticpointat535nm.5-ATR-ParM
mutants show different absorbance spectra with a
higher absorbance at 553 nm and lower absorbance at
Figure 1. ADP and ATP binding afﬁnity of 5-IATR-labeled
ParM. 5-IATR-labeled ParM (D63C/D224C/C287A) (open
symbols) and ParM (His6/K33A/D63C/T174A/T175N/
D224C/C287A) (closed symbols), both at a concentration
of 0.1 M, were titrated with ADP (circles) and ATP (tri-
angles). The ﬂuorescence of tetramethylrhodamine was
excited at 553 nm and detected at 577 nm. The equilib-
rium dissociation constants were determined by ﬁtting
quadratic binding curves to the data and are listed in
Table 1.
Figure 2. Absorbance and ﬂuorescence spectra of
tetramethylrhodamine-labeled ParM. Absorbance spectra
of ParM (His6/K33A/D63C/T174A/T175N/D224C/C287A)
labeled with 6-IATR (a) or 5-IATR (b). Spectra were mea-
sured in the absence of nucleotide and with 10, 30, 100,
and 2000 M ADP. The spectra show isosbestic points at
535 nm (a) and 532 nm (b). c) Fluorescence excitation and
emission spectra of 1 M 5-IATR-labeled (solid lines) and
6-IATR-labeled (dashed lines) ParM (His6/K33A/D63C/
T174A/T175N/D224C/C287A) in the absence of ADP
(lower intensity) and in the presence of 2 mM ADP (higher
intensity). Spectra were recorded at 553 and 577 nm ex-
citation and emission wavelengths.
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ADP additions increase the absorbance at 553 nm and
decrease the absorbance at 519 nm. The isosbestic
pointliesat532nm.Incontrasttotheabsorbancespec-
tra, the shape of the ﬂuorescence spectra of the two iso-
mers on ParM are almost identical with maximal excita-
tion and emission wavelengths of 553 and 577 nm for
5-ATR-ParM and 1 nm higher for 6-ATR-ParM (Figure 2,
panel c). However, the absolute ﬂuorescence intensity
is about 2-fold lower for 6-ATR-ParM.
Both the lower ﬂuorescence obtained with 6-ATR-
ParM and the absorbance spectra showing large differ-
ences in the intensity ratio of the bands at 519/550 nm
indicate that the two rhodamine isomers have a differ-
ent structural arrangement when attached to the cys-
teines on ParM. The 6-ATR moieties may form a stron-
ger stacking interaction on ParM, as the absorbance
ratio at 519/550 nm is higher and the ﬂuorescence in-
tensity is lower.
ADP and ATP Binding Afﬁnity. The dissociation con-
stants for the ﬁnal biosensors, 5-ATR- or 6-ATR-ParM,
and ADP are 30.2 0.9 and 37 2.5 M, respectively,
as determined by equilibrium titrations (Figure 1 and
Table 1). Thus, the K33A mutation increases ADP afﬁn-
ity. In addition, the maximal signal change is slightly
lower than for the tetramethylrhodamine-labeled ParM
variants without K33A mutation (15-fold instead of 19-
fold increase). However, the changes are small and do
not seriously affect the biosensor sensitivity.
The dissociation constants of ADP binding to all
tetramethylrhodamine-labeled variants are in the range
of 30–100 M, which are much higher values than
those of MDCC-ParM (0.5 M) or wild-type ParM
(2.4 M) (7, 21). The strongly reduced nucleotide afﬁn-
ityofIATR-labeledParMcouldbeduetothelargersizeof
the tetramethylrhodamines, along with the two cys-
teine mutations affecting the binding. Alternatively the
binding of ADP requires the cleft closure and hence the
disruption of the rhodamine stacking interaction. A sec-
ond tetramethylrhodamine-labeled double mutant
(D63C/K216C) has more than 10-fold higher ADP afﬁn-
ity than the (D63C/D224C) mutants (data not shown),
suggesting that weakened ADP binding is at least in part
due to the mutation D224C. In a previous use of tetram-
ethylrhodamine stacking sensing a protein conforma-
tion change with the phosphate binding protein, the ﬂu-
orophores had little effect on the afﬁnity for inorganic
phosphate(19),suggestingthatthestackingpersemay
not necessarily have a signiﬁcant effect on the energet-
ics. However, in the case of two tetramethylrhodamines
attachedtoafoldedprotein,theirabilitytostackandthe
resulting structure may be much more restricted than
in the situation where tetramethylrhodamines are rela-
tively free to ﬁnd the optimal conﬁguration, either in free
solution or attached to a ﬂexible peptide (18). Thus the
energetics of the stacking may vary between proteins.
Indeed, the spectral data with the phosphate binding
protein(19)suggestssuchdifferencesdooccur.Thelow
afﬁnity makes the tetramethylrhodamine versions less
sensitive in comparison to the MDCC sensor but more
suitable for high ATP concentrations.
ADP Binding Kinetics. Kinetics of ADP binding to
5-ATR- and 6-ATR-ParM were investigated in stopped-
ﬂow experiments taking advantage of the tetramethyl-
rhodamine signal change. Association kinetics were
measured under pseudo-ﬁrst-order conditions with an
excess of ADP (Figure 3, panel a). The ﬂuorescence
curves were well ﬁt by single exponentials, and the re-
sulting rate constants, kobs, increased with ADP concen-
tration in an approximately linear manner (Figure 3,
panel b), indicating that the rate of the signal change is
mainly controlled by the bimolecular binding step in the
concentration range examined. Data with 6-ATR-ParM
show a slight deviation from linearity, indicative of a
two-stepbindingmechanismbuttoosmalltodeduceki-
netic parameters for such a model (Figure 3, inset in
panel b and ﬁgure legend). Association and dissocia-
tion rate constants for a single binding step were calcu-
lated from the slope and intercept of linear regression
and are summarized in Table 1. The rate constants are
similar for the different tetramethylrhodamine-labeled
ParM variants. The dissociation constants, obtained
from the ratio of rate constants, are in very good agree-
ment with the values determined in equilibrium titra-
tions. Comparison with the ADP binding kinetics of
MDCC-ParM (7) shows that the strongly reduced ADP af-
ﬁnityintetramethylrhodamine-labeledParM(about2or-
ders of magnitude) is due to a combination of an order
of magnitude reduction in the association rate constant
and a similar size increase in the dissociation rate con-
stant. The maximum response time of the tetramethyl-
rhodamine biosensors is deﬁned by the dissociation
rate constants, 1/koff, which is 0.33 s for the slower
variant.Thus,thetetramethylrhodamine-basedParMbio-
sensors are well suited for real-time kinetic measure-
ments of ATPase and kinase activity. Finally, the ATP
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T174A/T175N/D224C/C287A) was measured using the
phosphate biosensor MDCC-PBP (data not shown) (24).
The catalytic activity was very low, 0.001 min1, even
at high ParM concentrations (10–20 M).
As described above, 5-ATR-ParM and 6-ATR-ParM
showed rather similar optical and ADP-binding proper-
ties. However, the absolute ﬂuorescence of 5-ATR-ParM
was 2-fold greater than that of 6-ATR-ParM (Figure 3,
panel c), and this is potentially advantageous in assays
using this sensor substoichiometrically. Therefore
5-ATR-ParM was chosen for further study in terms of
effect of salt conditions and use in kinase assays.
Effect of Salts on ADP Afﬁnity and Fluorescence
Response. All of the measurements described above
were performed at one buffer condition, namely, 30 mM
Tris·HCl pH 7.5, 25 mM KCl, 3 mM MgCl2. To address
the inﬂuence of different salt conditions on the biosen-
sorperformance,thesaltdependenciesofnucleotideaf-
ﬁnity and ﬂuorescence response were investigated for
5-ATR-ParM (Table 2). Fluorescence titrations were car-
ried out in the presence of different concentrations of
potassium and sodium chloride from 0 to 150 mM.
5-ATR-ParM showed the highest ADP afﬁnity in the pres-
ence of 150 mM potassium chloride and the lowest af-
ﬁnity in the absence of both salts. The differences in the
dissociationconstantsforADParemaximum10-foldbe-
tween the lowest and highest value. The ﬂuorescence
change was less sensitive to the nature and concentra-
tion of salt varying between 9- and 15-fold and seemed
to correlate with the ADP afﬁnity. Thus, the tetramethyl-
rhodamine biosensors should be applicable to a wide
range of salt conditions. However, there is a strict re-
quirement for magnesium ions since the ADP dissocia-
tion constant increased to 5 mM, when magnesium
ions were removed by EDTA (data not shown).
Kinase Activity Assays Using the ADP Biosensor. As
a ﬁrst example for a kinetic measurement using the
tetramethylrhodamine-ParM biosensor, the phosphory-
lation reaction of D-glucose catalyzed by hexokinase
from Saccharomyces cerevisiae was examined
(Figure 4). Steady-state kinetics of the phosphorylation
reaction were measured by monitoring ADP generation
with 5-ATR-ParM. The sensor was used at a concentra-
tion lower than that of ADP, so that the fractional satura-
tion of tetramethylrhodamine-ParM changes with ADP
concentration in a broad range about the dissociation
constant. Although at high ADP concentrations this
yields a nonlinear relationship between ﬂuorescence
signal and ADP, the response was approximately linear
at 10 M ADP (Figure 4, panel a). The presence of
1 mM ATP (the maximum concentration used) increased
the background level and so decreased the slope of
the calibration curve by about 20% (Figure 4, panel a),
and this was accommodated in the calibration as de-
scribed in Methods. Glucose, at the maximum concen-
tration used in the assay (2 mM), did not signiﬁcantly al-
ter the sensor response (data not shown). Time courses
ofADPgenerationweremonitoredeitheratconstantglu-
Figure 3. ADP binding kinetics of tetramethylrhodamine-
labeled ParM. a) Fluorescence time courses after mixing of
5-ATR-ParM with an excess of ADP in the stopped ﬂow.
The concentration of 5-ATR ParM was 0.1 M (mixing
chamber), and the micromolar ADP concentrations after
mixing are indicated in the graph. The data shown are
averages of three individual stopped-ﬂow traces. The ob-
served rate constants, kobs, were determined by single ex-
ponential curve ﬁtting. b) Plot of the observed rate con-
stants versus ADP concentration for 5-ATR- (closed circles)
and 6-ATR-ParM (open circles). Association and dissocia-
tion rate constants for a one-step binding model, obtained
from the slope and intercept of linear regression analy-
sis, are summarized in Table 1. There is a slight deviation
from linearity with the 6-ATR-ParM data. One way to ex-
plain this is to invoke two-step binding and ﬁt to a hyper-
bola (inset). However, the accessible concentration range
is not large enough to obtain parameters for two steps.
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and increasing glucose concentration. From Michaelis–
Menten plots (Figure 4, panels b and c) the parameters
KM
ATP  75  2 M and Vmax  5.0  0.2 M min1
were obtained for variation of ATP and KM
glucose  180
 9 M and Vmax  5.4  0.2 M min1 for variation
of the D-glucose concentration. The Vmax values yield an
average activity of 1.04  0.05 mol min1 per unit of
hexokinase, which is in good agreement with the unit
deﬁnition of the supplier, 1 M min1 unit1, under
similar experimental conditions (pH 7.6, 25 °C).
A second example of a kinase assay was performed
with mammalian, AMP-activated protein kinase, a key
enzyme in sensing cellular energy levels and controlling
metabolism in response to nutrients and hormones
(25). Phosphorylation kinetics of SAMS peptide, a pep-
tide derived from acetyl-CoA carboxylase with a single
phosphorylation site (26), was measured using 5-ATR-
ParM (Figure 5). In two sets of kinetic experiments, ei-
ther varying ATP or the concentration of SAMS peptide,
the time courses of ADP generation were monitored and
the initial rates were determined (Figure 5, insets).
Michaelis–Menten plots of the results from the two
data sets are shown in Figure 5, panel a and b. The
Michaelis–Menten parameters KM
ATP  35  3 M and
Vmax  20  2n Ms 1 were obtained from variation of
ATPandKM
SAMS361MandVmax191nMs 1
from data at different SAMS concentration. The average
value for the catalytic constant is kcat  9.8  0.6 s1.
The KM value for SAMS peptide is in good agreement
with data from other groups using either the recombi-
nant, phosphorylated enzyme (KM  47 M( 27)) or the
native rat liver enzyme (KM  30 M( 26)). The KM value
for ATP is about 2-fold lower than the 86 M measured
previously (28) using acetyl-CoA carboxylase as
substrate.
Performance of the Final ADP Biosensor. From the
four different ParM variants, doubly labeled with tetra-
methylrhodamine, 5-ATR-ParM (His6/K33A/D63C/
T174A/T175N/D224C/C287A) is likely to be generally
the most suitable ADP biosensor. Although the labeling
with the two isomers, 5- and 6-IATR, gives similar ADP
binding properties and signal change, the absolute ﬂuo-
rescence levels are higher with 5-ATR-ParM.
The tetramethylrhodamine-labeled ParM has some
characteristicsverydifferentfromthoseofthecoumarin-
labeled version (7) and so different potential applica-
tions as a biosensor for ADP. The ﬁrst important differ-
ence is that the 5-ATR-ParM can be used at lower
concentration than the ADP to be detected. Because of
the weak binding, the degree of saturation and thus the
ﬂuorescence will vary with ADP in a wide range around
the dissociation constant. While this method of mea-
surement is inherently less sensitive than quantitative
capture of ADP by a high afﬁnity sensor, it has the large
advantageofrequiringonlylowconcentrationofthebio-
sensor in the assay solution. A high concentration of
protein may interfere negatively with the assay, for ex-
ample, interacting with some component or introducing
inner ﬁlter effects, but is also expensive in material. In
TABLE 2. Fluorescence changes and dissociation constants of ADP and ATP binding to the
ﬁnal tetramethylrhodamine-ParM biosensor under different salt conditions
ADP ATP
Salt condition (F /F)a Kd (M)a (F /F)a Kd (M)a Kd ratio ATP/ADP
no additional salt 8.9  0.4 143  1.3 4 5000 35
25 mM KCl 14.9  0.6 30.2  0.9 6 3000 100
150 mM KCl 15.2  0.2 15.3  0.7 8 3000 200
25 mM NaCl 9.4  0.7 86  1.0 4 5000 60
150 mM NaCl 8.8  0.9 114  1.4 4 5000 45
25 mM KCl 	 125 mM NaCl 11.2  0.2 88  2.1 5 5000 55
aDissociation constants (Kd) and ﬂuorescence changes upon nucleotide binding (F	/F) to the ﬁnal biosensor, 5-ATR-ParM
(His6/K33A/D63C/T174A/T175N/D224C/C287A), were determined by ﬂuorescence titrations as described in the legend of
Figure 1. Titrations were carried out with 0.5 M ParM at 20 °C in 30 mM Tris·HCl pH 7.5, 3 mM MgCl2,5M BSA plus the
salt indicated.
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would be determined mainly by the sensitivity of the op-
tical detection system, the absolute ﬂuorescence of the
sensoritself,andtheaccuracyrequired.Asshowninthe
kinase assays, submicromolar concentrations of the
sensor can be easily used. Another practical conse-
quence of the weak nucleotide binding is that ADP con-
tamination in ATP would be less problematic than with
MDCC-ParM.
A second important advantage is the very weak ATP
binding of the tetramethylrhodamine-labeled sensor,
which allows use of high ATP concentrations. This is im-
portant, for example, where a very broad concentration
rangeisrequiredforsystemswithdifferentKMvalues.As
Figure 4. Steady-state assay of hexokinase activity using
the ADP biosensor. Phosphorylation of D-()-glucose by
hexokinase (0.005 units mL1) was measured by monitor-
ing ADP generation with 5-ATR-ParM (0.25 M). a) Calibra-
tion of the ﬂuorescence signal; 0.25 M 5-ATR-ParM was
titrated with ADP in the absence (closed circles) and in the
presence of 1 mM ATP (open circles). The slopes of linear
regression analysis of data with 0 and 1 mM ATP are 6.8 
0.2 and 5.4  0.1 M1, respectively. The inset shows the
complete titration curves on a logarithmic scale. The axis
descriptions are the same as in the main graph. b) Phos-
phorylation kinetics at varying ATP concentration and con-
stant 2 mM glucose. Initial rates are plotted versus ATP
concentration. Curve ﬁtting according to the Michaelis–
Menten equation results in the parameters KM  75 
2 M and Vmax  5.0  0.2 M min1. The inset shows
the time courses of ADP generation at 0, 0.01, 0.02, 0.04,
0.07, 0.1, 0.2, 0.3, 0.6, and 1 mM ATP. c) Plot of the initial
rates versus glucose concentration, measured at 1 mM
ATP. The Michaelis–Menten parameters of the ﬁtted curve
are KM, 180  9 M, and Vmax, 5.4  0.2 M min1. The
inset shows the time courses of ADP generation at 0, 0.02,
0.04, 0.07, 0.1, 0.15, 0.2, 0.3, 0.5, and 2 mM glucose.
Figure 5. Steady-state assay of AMP kinase activity using
the ADP biosensor. Kinetics of phosphorylation of SAMS
peptide by AMP kinase (2 nM) was measured by monitor-
ing ADP generation using 5-ATR-ParM (0.5 M). a) Plot of
the initial rates versus ATP concentration measured at con-
stant 300 M SAMS peptide. Curve ﬁtting according to the
Michaelis–Menten equation results in the parameters KM
 35  3 M, and Vmax,2 0 2n Ms 1. Inset: Time
courses of ADP generation at 0, 5, 10, 15, 30, 40, 80, 120,
and 400 M ATP. b) Plot of the initial rates versus SAMS
peptide concentration. The data were obtained at constant
400 M ATP. The Michaelis–Menten parameters from the
ﬁtted curve are KM  36  1 M, and Vmax,1 9 1n Ms 1.
Inset: Time courses of ADP generation at 0, 5, 10, 15, 20,
40, 60, 100, 160, and 300 M SAMS peptide.
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low micromolar to submicromolar ADP concentrations
can be detected on the background of millimolar ATP. Fi-
nally, tetramethylrhodamine is generally more photo-
stable than coumarins (9), and the ﬂuorescence is ex-
cited and detected at higher wavelengths. These
properties are likely to make tetramethylrhodamine-
ParM more suitable for applications that require high in-
tensity and/or long illumination and where optical inter-
ference with other assay components is critical, such
as in high-throughput screening. The low nucleotide af-
ﬁnity and optical properties of ATR-ParM are also a good
starting point for further development of the biosensor
to enable ADP measurement in cells.
METHODS
Plasmids. ParM expression plasmids were derived from plas-
mid pJSC1 (7, 23). Point mutations in ParM were introduced by
QuikChange site-directed mutagenesis (Stratagene). All ParM
variants except the triple mutants ParM (D63C/D224C/C287A)
and (D63C/K216C/C287A) contain a hexahistidine tag at the
C-terminus, generated by site-directed mutagenesis as de-
scribed previously (7).
Expression and Puriﬁcation of ParM Mutants. ParM variants
were synthesized in E. coli BL21-Ai cells (Invitrogen) as de-
scribed (7). ParM without an afﬁnity tag was puriﬁed by poly-
merization/depolymerization, His6-tagged ParM was puriﬁed by
Ni-chelate afﬁnity chromatography (HisTrap HP, GE Healthcare),
both followed by size exclusion chromatography on Superdex 75
(GE Healthcare). The puriﬁcation was performed as described
in detail previously (7) with the following modiﬁcations. The
buffers for Ni-chelate chromatography were supplemented with
1 mM tris(2-carboxyethyl)phosphine, and the buffer for size ex-
clusion chromatography was supplemented with 5 mM DTT.
Concentration of ParM mutants was determined by absorbance
measurements using the extinction coefﬁcient 34,380 M1 cm1
at 280 nm, calculated from the primary sequence (29).
Labeling of ParM Mutants with IATR. All steps were performed
in 30 mM Tris·HCl pH 7.5, 25 mM KCl. Before labeling, DTT was
removed on a PD10 column (GE Healthcare). Double labeling
with tetramethylrhodamine was typically performed on a scale
of 10–20 mg protein. One hundred micromolar ParM and
400 M 5- or 6-IATR (30, 31) were incubated in degassed buffer
at 22 °C with end-over-end stirring for 90 min. Next, 2 mM so-
dium 2-mercaptoethanesulfonate was added, and stirring was
continued for another 15 min. Reaction mixtures were centri-
fuged (14,000g, 10 min, 4 °C), and the supernatant was ﬁltered
through a 0.2 m syringe ﬁlter (Acrodisc, Pall Corporation). Ex-
cess ﬂuorophore and sodium 2-mercaptoethanesulfonate were
removed on a PD10 column (GE Healthcare). The eluate was
loaded ona1m LHiTrapQ HP column (GE Healthcare). The col-
umn was washed (10 column volumes), and the labeled ParM
was eluted by applying a linear gradient of 25–200 mM KCl over
40 column volumes. Fractions showing the highest ﬂuores-
cence change upon ADP binding were pooled, and the labeled
protein was concentrated in an Amicon Ultracentrifugal ﬁlter de-
vice (Millipore Corporation) to 10 mg mL1. Aliquots were
shock-frozen in liquid nitrogen and stored at 80 °C. Double la-
beling was conﬁrmed by electrospray-ionization mass spectrom-
etry. The measured masses differed by 0.5 Da from the theo-
retical values for the doubly labeled proteins. Concentration of
tetramethylrhodamine-labeled ParM mutants were determined
from the absorbance spectra using the extinction coefﬁcient of
a small molecule thiol adduct of 5-IATR at its isosbestic point,

528  52,000 M1 cm1 (31). Note that differences in the spec-
tra when attached to ParM may lead to a small error in the cal-
culated concentrations.
Nucleotides. ADP and ATP (Sigma-Aldrich) were purchased at
the highest purity available. ATP was further puriﬁed by anion-
exchange, and the purity of nucleotides was analyzed by HPLC
as described (7). The concentrations of ADP and ATP were deter-
mined from their absorbance spectra in 20 mM Tris·HCl pH 7.5
using the extinction coefﬁcient 
259  15,400 cm1.
Fluorescence and Light Scattering Measurements. Fluores-
cence spectra and titrations were measured in a Cary Eclipse
spectroﬂuorimeter (Varian). Excitation and emission spectra
were recorded with 5 nm slit width at emission and excitation
wavelength of 577 and 553 nm, respectively. In titration experi-
ments tetramethylrhodamine ﬂuorescence was measured at
the same excitation/emission wavelength. Titration data were
analyzed with a quadratic binding curve using the program Graﬁt
5.0 (7).
Stopped-ﬂow experiments were performed using a HiTech
SF61 DX2 instrument equipped with a Xe/Hg lamp (TgK Scien-
tiﬁc). Association kinetics of tetramethylrhodamine-labeled
ParM and ADP was measured under pseudo-ﬁrst-order condi-
tions by mixing 0.2 M labeled ParM (syringe concentration)
with excess ADP. Tetramethylrhodamine ﬂuorescence was ex-
cited at 553 nm and ﬂuorescence emission was detected after
passing 570 nm cutoff ﬁlter. Data were analyzed by single expo-
nential curve ﬁtting using KinetAsyst 3 (TgK Scientiﬁc) All ﬂuo-
rescence measurements were carried out in 30 mM Tris·HCl
pH 7.5, 25 mM KCl, 3 mM MgCl2, and 5 M BSA at 20 °C un-
less stated otherwise.
Filament formation of labeled ParM mutants was measured
by right angle light scattering at 340 nm in a Cary Eclipse spec-
troﬂuorimeter (Varian) as described (7). The assay was per-
formed at 20 °C in 30 mM Tris·HCl pH 7.5, 25 mM KCl, 3 mM
MgCl2.
Steady-StateAssaysofHexokinaseandAMPKinaseActivity.Ki-
netics of phosphorylation of D-(	)-glucose by hexokinase from
S. cerevisiae (Sigma-Aldrich) were monitored with the ADP bio-
sensor 5-ATR-ParM (His6/K33A/D63C/T174A/T175N/D224C/
C287A) using a Cary Eclipse spectroﬂuorimeter (Varian). Mea-
surements were carried out in 50 mM Tris·HCl pH 7.5, 25 mM
KCl, 10 mM MgCl2, and 2.5 M BSA at 20 °C. Reactions were set
up with 0.25 M 5-ATR-ParM, 0.005 unit mL1 hexokinase, and
at constant 1 mM ATP and varying concentrations of glucose
(20–2000 M) or at constant 2 mM glucose and increasing ATP
concentrations. The reaction was started by the addition of hex-
okinase. Tetramethylrhodamine ﬂuorescence was excited at
553 nm and detected at 577 nm. For calibration of the ﬂuores-
cence signal 0.25 M 5-ATR-ParM was titrated with ADP in the
absence of ATP and in the presence of 1 mM ATP (maximal con-
centration used). In the range up to 10 M ADP the data could
be approximated by a linear dependence (Figure 4, panel a).
The slope from linear regression analysis was 6.8  0.2 M1
in the absence of ATP and about 20% lower, 5.4  0.1 M1,i n
the presence of 1 mM ATP (Figure 4, panel a). The latter value
was used to calibrate all data obtained at maximum ATP (1 mM).
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tions, a slope for calibration was calculated by linear interpola-
tion between the values at 0 and 1 mM ATP. In contrast to ATP,
glucose (2 mM) did not have a signiﬁcant effect on the ﬂuores-
cence response of tetramethylrhodamine-ParM.
Phosphorylation kinetics of SAMS peptide (26) by AMP ki-
nase (phosphorylated, heterotrimeric complex, 
)( 27) were
measured using 5-ATR-ParM (His6/K33A/D63C/T174A/T175N/
D224C/C287A) analogous to the procedure described for the
hexokinase assay. Measurements were carried out in 50 mM
Tris·HCl pH 7.5, 80 mM KCl, 5 mM MgCl2, 2 mM DTT, and 5 M
BSA at 20 °C. The concentrations used were 2 nM AMP kinase,
0.5 M ParM and either constant 400 M ATP and varying con-
centrations of SAMS peptide or constant 300 M SAMS peptide
and varying ATP.
All experiments were performed at least in duplicate and val-
ues given in the text, tables, and ﬁgure legends are averages
of these.
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